For example, the JAK2/STAT3 signaling pathway plays an important role in the angiogenesis of non-small cell lung cancer (NSCLC), and blocking this pathway may inhibit the expression of angiogenic cytokines. Here, JAK2 is linked to non-small cell lung carcinoma.